EyePoint Pharmaceuticals Statistics
Total Valuation
EYPT has a market cap or net worth of $402.55 million. The enterprise value is $108.44 million.
Important Dates
The last earnings date was Wednesday, May 7, 2025, before market open.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
EYPT has 68.81 million shares outstanding. The number of shares has increased by 41.51% in one year.
Current Share Class | 68.81M |
Shares Outstanding | 68.81M |
Shares Change (YoY) | +41.51% |
Shares Change (QoQ) | +8.07% |
Owned by Insiders (%) | 0.95% |
Owned by Institutions (%) | 74.78% |
Float | 43.63M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.32 |
Forward PS | 29.85 |
PB Ratio | 1.35 |
P/TBV Ratio | 1.35 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.93 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.85, with a Debt / Equity ratio of 0.08.
Current Ratio | 7.85 |
Quick Ratio | 7.65 |
Debt / Equity | 0.08 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -11,526.43 |
Financial Efficiency
Return on equity (ROE) is -53.54% and return on invested capital (ROIC) is -34.89%.
Return on Equity (ROE) | -53.54% |
Return on Assets (ROA) | -29.16% |
Return on Invested Capital (ROIC) | -34.89% |
Return on Capital Employed (ROCE) | -50.29% |
Revenue Per Employee | $339,648 |
Profits Per Employee | -$889,582 |
Employee Count | 165 |
Asset Turnover | 0.16 |
Inventory Turnover | 5.60 |
Taxes
In the past 12 months, EYPT has paid $90,000 in taxes.
Income Tax | 90,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.61% in the last 52 weeks. The beta is 1.60, so EYPT's price volatility has been higher than the market average.
Beta (5Y) | 1.60 |
52-Week Price Change | -51.61% |
50-Day Moving Average | 6.09 |
200-Day Moving Average | 7.96 |
Relative Strength Index (RSI) | 44.88 |
Average Volume (20 Days) | 642,547 |
Short Selling Information
The latest short interest is 10.07 million, so 14.64% of the outstanding shares have been sold short.
Short Interest | 10.07M |
Short Previous Month | 11.82M |
Short % of Shares Out | 14.64% |
Short % of Float | 23.08% |
Short Ratio (days to cover) | 13.27 |
Income Statement
In the last 12 months, EYPT had revenue of $56.04 million and -$146.78 million in losses. Loss per share was -$2.43.
Revenue | 56.04M |
Gross Profit | 38.18M |
Operating Income | -161.37M |
Pretax Income | -86.74M |
Net Income | -146.78M |
EBITDA | -159.64M |
EBIT | -161.37M |
Loss Per Share | -$2.43 |
Full Income Statement Balance Sheet
The company has $318.19 million in cash and $24.08 million in debt, giving a net cash position of $294.11 million or $4.27 per share.
Cash & Cash Equivalents | 318.19M |
Total Debt | 24.08M |
Net Cash | 294.11M |
Net Cash Per Share | $4.27 |
Equity (Book Value) | 298.40M |
Book Value Per Share | 4.34 |
Working Capital | 285.31M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$148.18 million and capital expenditures -$3.13 million, giving a free cash flow of -$151.31 million.
Operating Cash Flow | -148.18M |
Capital Expenditures | -3.13M |
Free Cash Flow | -151.31M |
FCF Per Share | -$2.20 |
Full Cash Flow Statement Margins
Gross margin is 68.12%, with operating and profit margins of -287.94% and -261.91%.
Gross Margin | 68.12% |
Operating Margin | -287.94% |
Pretax Margin | -261.75% |
Profit Margin | -261.91% |
EBITDA Margin | -284.85% |
EBIT Margin | -287.94% |
FCF Margin | n/a |
Dividends & Yields
EYPT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -41.51% |
Shareholder Yield | -41.51% |
Earnings Yield | -36.46% |
FCF Yield | -37.59% |
Analyst Forecast
The average price target for EYPT is $24.00, which is 310.26% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $24.00 |
Price Target Difference | 310.26% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 66.30% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on December 9, 2020. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Dec 9, 2020 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
EYPT has an Altman Z-Score of 1.38 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.38 |
Piotroski F-Score | 1 |